Concepedia

Lolita Stribinskiene

LS

Statistics

Publications

4

Citations

264

H-Index

4

Active since

1996

Affiliations

James Graham Brown Foundation(Current)

University of Louisville

Lolita Stribinskiene is an author at James Graham Brown Foundation specializing in apoptosis, apoptosis in cancer, and oncology.

Publications per year

1996–1999

4

Publications

4

Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival.

Richard B. Lock, Lolita Stribinskiene · PubMed · 1996 · 205 citations

Medicine, Oncology, Pharmacology +17

Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2′-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicin

Mary Jane Elliott, Lolita Stribinskiene, Richard B. Lock · Cancer Chemotherapy and Pharmacology · 1998 · 23 citations

Life Sciences, Cell Biology, Oncology +13

Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide

Mary Jane Elliott, Kathleen M. Murphy, Lolita Stribinskiene et al. · Cancer Chemotherapy and Pharmacology · 1999 · 21 citations

Life Sciences, Cell Biology, Oncology +17

Potentiation of etoposide-induced apoptosis by staurosporine in human tumor cells is associated with events downstream of DNA-protein complex formation

Richard B. Lock, Bruce S. Thompson, Daniel M. Sullivan et al. · Cancer Chemotherapy and Pharmacology · 1997 · 15 citations

Life Sciences, Oncology, Pharmacology +16

1–4 of 4